Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 61269-386
  • Package NDC 61269-386-12
  • Application number NDA050786
  • SPL ID fa1bf0cb-c69b-40d1-b543-828ca1cd5b58
  • SPL set ID c29bfde9-5eb4-422a-bd30-4bce45e73dc0
  • UNII R3O80H60KX
  • UNII 140QMO216E
  • UNII P6R62377KV

What the source publishes

Labeler
H2-Pharma, LLC
Active ingredients
Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride
Form
CAPSULE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA AUTHORIZED GENERIC
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:61269-386_fa1bf0cb-c69b-40d1-b543-828ca1cd5b58
{
  "name": "Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride",
  "splId": "fa1bf0cb-c69b-40d1-b543-828ca1cd5b58",
  "labels": [
    {
      "setId": "c29bfde9-5eb4-422a-bd30-4bce45e73dc0",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c29bfde9-5eb4-422a-bd30-4bce45e73dc0",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c29bfde9-5eb4-422a-bd30-4bce45e73dc0"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "H2-Pharma, LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "10 BLISTER PACK in 1 BOX (61269-386-12)  / 12 CAPSULE in 1 BLISTER PACK",
      "package_ndc": "61269-386-12",
      "identifierStatus": "well-formed",
      "marketing_end_date": "20261120",
      "marketing_start_date": "20250701"
    }
  ],
  "productId": "61269-386_fa1bf0cb-c69b-40d1-b543-828ca1cd5b58",
  "useDomain": "unknown",
  "dosageForm": "CAPSULE",
  "productNdc": "61269-386",
  "deaSchedule": null,
  "genericName": "Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": "20261120",
  "activeIngredients": [
    {
      "name": "BISMUTH SUBCITRATE POTASSIUM",
      "strength": "140 mg/1"
    },
    {
      "name": "METRONIDAZOLE",
      "strength": "125 mg/1"
    },
    {
      "name": "TETRACYCLINE HYDROCHLORIDE",
      "strength": "125 mg/1"
    }
  ],
  "applicationNumber": "NDA050786",
  "marketingCategory": "NDA AUTHORIZED GENERIC",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20250701",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175435",
      "M0014907"
    ],
    "unii": [
      "R3O80H60KX",
      "140QMO216E",
      "P6R62377KV"
    ],
    "spl_set_id": [
      "c29bfde9-5eb4-422a-bd30-4bce45e73dc0"
    ],
    "pharm_class_cs": [
      "Nitroimidazoles [CS]"
    ],
    "pharm_class_epc": [
      "Nitroimidazole Antimicrobial [EPC]"
    ],
    "manufacturer_name": [
      "H2-Pharma, LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": null
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:61269-386_fa1bf0cb-c69b-40d1-b543-828ca1cd5b58"